Blog

Clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine (“Insilico”) announces that it has received approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for ISM3412, a small molecule inhibitor of MAT2A for the potential treatment of

Tumor-resident microbiota in breast cancer promotes both the initiation and progression of cancer. However, the potential of targeting microbiota to enhance the efficacy of breast cancer treatment has not been comprehensively explored. In this study, researchers analyzed the microbial composition within breast tumors and identified a notable enrichment of ETBF in

International DNA Day Launch for Hong Kong’s Moonshot for Biology Credit: Earth Biogenome Project: Hong Kong International DNA Day Launch for Hong Kong’s Moonshot for Biology The first emblematic species sequenced by the Hong Kong Biodiversity Genomics Consortium are published to coincide with International DNA

“[…] we identified multiple proteins affecting COVID-19 and aging.” Credit: 2024 Zhao et al. “[…] we identified multiple proteins affecting COVID-19 and aging.” BUFFALO, NY- April 24, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen

Dana-Farber Cancer Institute nurse scientists and clinicians are presenting key studies and projects at the 49th annual Oncology Nursing Society (ONS) Congress on April 24-28, 2024, in Washington, D.C. Credit: Courtesy of Dana-Farber Cancer Institute Dana-Farber Cancer Institute nurse scientists and clinicians are presenting key

Recently, the research group of Prof. HUANG Qing at Hefei Institutes of Physical Science, Chinese Academy of Sciences developed DNA-aptamer based surface enhanced Raman spectroscopy (SERS) probes for the study of immune system biomarker related bioprocesses in cancer cell metabolism. Credit: Muhammad Muhammad Recently, the

A research team including scientists from the CNRS1 has discovered that cancer, one of the leading causes of death worldwide, can be caused entirely by epigenetic changes2, in other words, changes that contribute to how gene expression is regulated, and partly explain why, despite an

As our battle against cancer rages on, the quest for more sophisticated and realistic models to study tumor development has never been more critical. Until now, research has relied on animal models and simplified cell culture methods, which are valuable but cannot fully capture the

Long non-coding ribonucleic acids (lncRNAs), despite not coding for any protein, can play a significant role in cancer formation, progression, and treatment outcomes. One such lncRNA of interest is MALAT1, abbreviated for metastasis-associated lung adenocarcinoma transcript 1. Initially noted for its impact on gene expression in